Slow Bull
The market, slowly. SATURDAY, 26 SEPTEMBER 2026

NP Life Sciences Health Industry Group Inc.

ACAT SEC CIK 1781726
Follow NP Life Sciences Health Industry Weekly email: filings, results, news

Financials

Reported figures only · latest: Q4 2023 USD · US GAAP
Revenue, last quarter $10K −78.3% vs same quarter last year
Net income −$15.4K −192.5% vs same quarter last year
EPS, diluted -
Operating cash flow −$13.9K −112.1% vs same quarter last year
Revenue by quarter
$17.5K
$10K
Q3 23 Q4 23

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income6 fiscal years
  • Revenue
  • Net income
−$200K−$100K$0$100K$200KFY18FY19FY20FY21FY22FY23
Show the numbers
YearRevenueNet income
FY23$164.6K−$2.9K
FY22$102K−$18.9K
FY21$35K−$65.7K
FY20$15K−$131.1K
FY19$43K−$108.8K
FY18--
MarginsShare of revenue
  • Operating margin
  • Net margin
−1000%−750%−500%−250%0%FY18FY19FY20FY21FY22FY23
Show the numbers
YearOperating marginNet margin
FY23−0.4%−1.8%
FY22−18.5%−18.5%
FY21−187.7%−187.7%
FY20−873.9%−873.8%
FY19−253.2%−253.1%
FY18--
Net margin vs the sectorMedian of Industrials companies filing with the SEC
  • NP Life Sciences Health Industry
  • Industrials median
−1000%−750%−500%−250%0%250%FY18FY19FY20FY21FY22FY23
Show the numbers
YearNP Life Sciences Health IndustryIndustrials median
FY23−1.8%2.8%
FY22−18.5%2.1%
FY21−187.7%1.4%
FY20−873.8%−2.8%
FY19−253.1%2.5%
FY18-3.5%

News

No stories filed under NP Life Sciences Health Industry yet - coverage appears here as the news feed clusters it.